Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Molecular Profile | KIT W557G |
Therapy | Imatinib |
Indication/Tumor Type | extraskeletal myxoid chondrosarcoma |
Response Type | predicted - sensitive |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
KIT W557G | extraskeletal myxoid chondrosarcoma | predicted - sensitive | Imatinib | Case Reports/Case Series | Actionable | In a clinical case study, Gleevec (imatinib) treatment resulted in stable disease lasting at least 3 years in a patient with extraskeletal myxoid chondrosarcoma harboring KIT W557G (PMID: 34446510). | 34446510 |
PubMed Id | Reference Title | Details |
---|---|---|
(34446510) | Sustained response to imatinib in patient with extraskeletal myxoid chondrosarcoma and novel KIT mutation. | Full reference... |